Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of function of the chromatin remodeling gene <i>INO80D</i> leads to neurogenic features of schizophrenia.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Genetic regulation of the estrogen receptor and inherited predisposition to breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Long-read DNA and RNA sequencing for inherited polyposis and colorectal cancer: cryptic intronic variants and multiple mutational mechanisms.

Journal of medical genetics·2025
Same author

TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers.

Journal of the National Cancer Institute·2024
Same author

Long-read DNA and cDNA sequencing identify cancer-predisposing deep intronic variation in tumor-suppressor genes.

Genome research·2024
Same author

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.

JAMA oncology·2024

Related Experiment Video

Updated: May 11, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Genetic heterogeneity in human disease.

Jon McClellan1, Mary-Claire King

  • 1Department of Psychiatry, University of Washington, Seattle, WA 98195-7720, USA. drjack@uw.edu

Cell
|April 21, 2010
PubMed
Summary

Rare, severe mutations significantly contribute to complex human diseases. Advanced sequencing technologies now enable the identification of these disease-causing genetic variants and their associated genes.

Area of Science:

  • Genetics
  • Human Disease
  • Evolutionary Biology

Background:

  • Complex human diseases are influenced by genetic factors.
  • Genetic heterogeneity arises from evolutionary forces introducing new variants each generation.
  • Rare mutations with severe effects are increasingly recognized as significant contributors to disease.

Purpose of the Study:

  • To highlight the role of rare, severe mutations in complex human diseases.
  • To discuss the impact of evolutionary forces on genetic heterogeneity in disease.
  • To explore the potential of current sequencing technologies in identifying disease-causing mutations.

Main Methods:

  • Review of existing evidence on rare mutations and complex diseases.
  • Analysis of evolutionary mechanisms generating genetic diversity.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Experiment Videos

Last Updated: May 11, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

  • Assessment of the capabilities of modern sequencing technologies.

    • Main Results:

    • Strong evidence links rare, severe mutations to a substantial portion of complex human diseases.
    • Evolutionary processes continuously introduce genetic variants, contributing to disease heterogeneity.
    • Sequencing technologies provide a powerful means to discover these rare mutations and genes.

    Conclusions:

    • Rare mutations are critical factors in understanding complex human diseases.
    • Genetic heterogeneity driven by evolution necessitates advanced detection methods.
    • Current sequencing advancements offer promising avenues for identifying genetic underpinnings of disease.